You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Colorectal cancer

Capecitabine and oxaliplatin in the adjuvant treatment of stage 3 (Dukes' C) colon cancer

  • Technology appraisal guidance
  • Reference number: TA100
  • Published:  26 April 2006
  • Guidance
  • Tools and resources
  • Information for the public
  • History

Appendix A: decision paper presented to the Institute's Guidance Executive

Appendix A: decision paper presented to the Institute's Guidance Executive Appendix A: decision paper presented to the Institute's Guidance Executive
04 July 2011
(58.63 Kb 17 sec)

Adobe Acrobat reader required.

  Adobe Acrobat reader required.

This page was last updated: 04 July 2011

Back to top